Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Using existing drugs for new treatments is cost-effective and safer.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Possible link between COVID-19 and hair loss; more research needed.

New treatments for hair loss are being developed using molecular biology.

Analog 23 is a promising compound for prostate cancer treatment.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Seborrheic alopecia in adolescents is linked to hormones, stress, and lifestyle, and can be treated with medication, lifestyle changes, and therapy.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

New treatments for male hypogonadism are effective and should be personalized.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.